Next Article in Journal
COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study
Next Article in Special Issue
Cell Surface Fibroblast Activation Protein-2 (Fap2) of Fusobacterium nucleatum as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics Approach
Previous Article in Journal
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine
 
 
Review

Article Versions Notes

Vaccines 2022, 10(8), 1165; https://doi.org/10.3390/vaccines10081165
Action Date Notes Link
article xml file uploaded 22 July 2022 04:40 CEST Original file -
article xml uploaded. 22 July 2022 04:40 CEST Update https://www.mdpi.com/2076-393X/10/8/1165/xml
article pdf uploaded. 22 July 2022 04:40 CEST Version of Record https://www.mdpi.com/2076-393X/10/8/1165/pdf
article html file updated 22 July 2022 04:41 CEST Original file -
article html file updated 13 August 2022 03:03 CEST Update https://www.mdpi.com/2076-393X/10/8/1165/html
Back to TopTop